🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
This research study is evaluating a drug called Palbociclib in combination ...
Status
Completed
Location
University of California, San Francisco
Start Date
2014-01
Trial ID
NCT02040857
Treatments Being Tested
AMBRE is a phase III study comparing two standard treatments as initial met...
Status
Active Not Recruiting
Location
Centre Hospitalier Lyon Sud
Start Date
2020-06-11
Trial ID
NCT04158362
This prospective, response-adapted phase II study evaluates the efficacy an...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2026-05-20
Trial ID
NCT07616427
Treatments Being Tested
This study is a prospective, open-label, multicenter, randomized controlled...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT07005557
Treatments Being Tested
RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone th...
Status
Unknown
Location
Federico II University Medical School
Start Date
2008-05
Trial ID
NCT00688194
Treatments Being Tested
Primary Objective: To determine whether amcenestrant per overall survival ...
Status
Terminated
Location
Alabama Oncology - St. Vincent's Birmingham- Site Number : 8400008
Start Date
2019-10-22
Trial ID
NCT04059484
Treatments Being Tested
The purpose of this study is to investigate the relationship between the si...
Status
Unknown
Location
Korea University Anam Hopital
Start Date
2009-03
Trial ID
NCT00973505
Treatments Being Tested
The present multi-center, open-label, single-arm study aims to evaluate the...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-06
Trial ID
NCT01626222
Treatments Being Tested
Hormone receptor-positive breast cancer accounts for about 70% of all breas...
Status
Recruiting
Location
Cancer Hospital Affiliated to Harbin Medical University
Start Date
2021-07-19
Trial ID
NCT04476485
Treatments Being Tested